title: Early closure of European Pimagedine trial. Steering Committee. Safety Committee.
authors.forename: G
authors.initials: G
authors.lastname: Viberti
authors.forename: G
authors.initials: G
authors.lastname: Slama
authors.forename: G
authors.initials: G
authors.lastname: Pozza
authors.forename: A
authors.initials: A
authors.lastname: Czyzyk
authors.forename: R W
authors.initials: RW
authors.lastname: Bilous
authors.forename: A
authors.initials: A
authors.lastname: Gries
authors.forename: H
authors.initials: H
authors.lastname: Keen
authors.forename: J H
authors.initials: JH
authors.lastname: Fuller
authors.forename: G
authors.initials: G
authors.lastname: Menzinger
mesh_terms: D000419:Albuminuria / Q000188:drug therapy*; D032982:Contracts; D004345:Drug Industry; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D004992:Ethics, Medical; D005060:Europe; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D011641:Public Relations; D016032:Randomized Controlled Trials as Topic; D035842:Research Subjects; D036302:Therapeutic Human Experimentation
chemical_list: D004791:Enzyme Inhibitors; D006146:Guanidines; C004479:pimagedine